Author of

• 25934

  +

  P1.14 - Thymoma/Other Thoracic Malignancies (Not CME Accredited Session) (ID 946)

  • Event: WCLC 2018
  • Type: Poster Viewing in the Exhibit Hall
  • Track:
  • Presentations: 1
  • Moderators:
  • Coordinates: 9/24/2018, 16:45 - 18:00, Exhibit Hall

  • 26638

    +

    P1.14-01 - Current Practices in the Management of Malignant Pericardial Effusions: A Survey Amongst Members of the European Society of Thoracic Surgeons. (ID 14287)

    16:45 - 18:00  |  Author(s): Marco Scarci
    • Abstract

    Background
    

    Malignant pericardial effusion (MPE) is a rare presentation, is associated with a high morbidity and mortality, and may be challenging to manage.

    We sought to determine the current practice in the management of MPE among members of the European Society of Thoracic Surgeons (ESTS).

    a9ded1e5ce5d75814730bb4caaf49419 Method
    

    A cross-sectional survey examining the case volume, initial workup, urgent and non-urgent management of MPE was developed by the authors, following a review of the literature. The survey was circulated to ESTS membership in an internet-based survey format, between February and April 2016.

    4c3880bb027f159e801041b1021e88e8 Result
    

    136 consultant thoracic surgical colleagues responded; representing 43 countries across 5 continents, and with an average (mean±SD) of 14±9 years’ independent practice. Annual volume of MPE referral was 9±12 cases (median, range = 5, 0 to 80).

    Echocardiography (88%), computed tomography (85%) and pericardial fluid cytology (54%) are the preferred initial investigations.

    In clinically stable patients, pericardiocentesis is the preferred (60%) intervention in first-presentations; with 80% of patients with recurrent effusions being offered pleuro-pericardial fenestration (66% thoracoscopically, 14% thoracotomy). 43 to 50% of respondents would use an intrapericardial sclerosant as part of their management of recurrent MPEs, depending on primary pathology.

    The preferred approach options in patients with cardiac tamponade are ultrasound-guided pericardiocentesis (56%), subxiphoid pericardiotomy (26%) and landmark pericardiocentesis (11%).

    Only 24% of respondents felt that their practice was informed by published clinical guidelines, with 53% expressing a need for updating of current guidance.

    8eea62084ca7e541d918e823422bd82e Conclusion
    

    There is much variation, and reported uncertainty, in the management of MPEs in clinical practice. There is, additionally, lack of engagement with currently-available clinical guidance.

    6f8b794f3246b0c1e1780bb4d4d5dc53